CD4 and cancer: CCL17 is a known STAT6 transcriptional target [41] and chemoattractant that recruits various CCR4 + immune cells—such as CD8+ or CD4+ T-cells, and macrophages—in murine and canine cancer models, in addition to human tumors [42–45].